Case File 002
The Plateau Breakthrough
An elite practice that was already winning — and still had a hidden crack. Normalized EBITDA margin from ~25% to ~35% in 12 months, without adding a single chair.
All practice identifiers have been sanitized per client confidentiality agreements. The methodology, data architecture, and financial outcomes documented here are exact.
Normalized EBITDA Margin
Normalized EBITDA
Enterprise Value
Added Capacity
Practice Profile
Elite, referral-driven general practice, Southern California. Strong team, real culture, modern complete-health dentistry.
Already performing well. Profitability was healthy and the owner had already worked with the top names in the consulting field.
Not a turnaround. A game of inches — the kind of practice most advisors would call finished.
The Trigger
The question was never whether the practice was good. It was whether good was hiding anything. An elite team and a healthy margin are exactly the conditions under which the last increment of value goes unexamined — because nobody is looking for a problem they have no reason to believe exists.
The Method
It was hiding something. The same forensic cadence — benchmark, SOP, accountability — applied to a polished practice, with situational data doing the finding: case-dollar acceptance sliced by CDT code, by dollar tier, by exam type. That granularity pinpoints the crack a dashboard average conceals.
We rebuilt objection handling together, installed marketing with true source attribution, and refined the treatment tracker the team already used. Nothing dramatic — a series of precise, data-located corrections on an already-strong base. Even an excellent team has one crack somewhere.
The Outcome
A ~$200,000 revenue lift in 12 months and normalized EBITDA margin expansion from ~25% to ~35% — without adding capacity, on a practice that was already running well.
Proof that the ceiling on a strong practice is almost always operational, not clinical — and that the margin nobody is looking for is exactly the margin a buyer's diligence team will find first.
The Valuation Impact
Starting Value
~$758KIndividual-buyer market (SDE basis)
Current Value
~$1.19MSDE basis, range ~$1.05M–$1.33M
Run through our own valuation model, the work paid three ways — and taught one hard lesson:
Income now. The ~$200K of collected growth improved the owner's financial position immediately, every year before any sale.
Asset value. Enterprise value moved from ~$758K to ~$1.19M, and the EBITDA gain is documented and defensible under diligence — not a number that evaporates in a buyer's Quality of Earnings review.
The lesson: size sets your market. Even at elite 35% margins, this practice stays on the individual-buyer (SDE) basis because it is under ~$1.5M in collections. World-class operations do not, by themselves, move you into the institutional EBITDA band — scale does. Quality maximizes value within your market; size determines which market you are in.
"Even a great, well-polished team has a crack somewhere. The situational data is what finds it."
— James DeLuca